Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Catel-Manzke syndrome is a rare bone disease characterized by bilateral hyperphalangy and clinodactyly of the index finger typically in association with Pierre Robin sequence comprising micrognathia, cleft palate and glossoptosis.
Features include always present findings: Joint hypermobility, Pierre-Robin sequence, and Micrognathia; and very common findings: Cleft palate. 48 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 4 | Joint dislocation, Joint hypermobility, Short femur |
Arms and legs | 4 | Ulnar deviation of the 2nd finger, Clinodactyly of the 5th finger, Hyperphalangy of the 2nd finger |
Head and neck | 3 | Cleft palate, Cleft upper lip, High palate |
Brain and nerves | 2 | Seizure, Global developmental delay |
Growth and development | 2 | Postnatal growth retardation, Intrauterine growth retardation |
Heart and blood vessels | 1 | Ventricular septal defect |
TGDS function has not been fully characterized.
Catel-Manzke syndrome is caused by mutations in the TGDS gene on chromosome 13.
Genetic testing for TGDS is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for Catel-Manzke syndrome has been reported in the published literature.
Phenotype severity distribution: 3 always present features, 1 very common feature, 5 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Catel-Manzke syndrome.
106 publications have been identified in PubMed for Catel-Manzke syndrome. Kisho has analyzed 70 by research type. Research spans Review / Meta-Analysis (30%), Epidemiology / Natural History (23%), and Case Report / Case Series (16%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 21 | 30% |
Disease patterns and progression | 16 | 23% |
Patient case studies | 11 | 16% |
Laboratory research | 9 | 13% |
Testing and diagnosis research | 6 | 9% |
Clinical study results | 5 | 7% |
Other research | 1 | 1% |
New treatment approaches | 1 | 1% |
Mokhtari A (2026). [PMID: 40842263](https://pubmed.ncbi.nlm.nih.gov/40842263/). *Clin Genet*. [Basic Science / Preclinical]
Kutti Sridharan G (2026). [PMID: 32809380](https://pubmed.ncbi.nlm.nih.gov/32809380/). *Unknown Journal*. [Epidemiology / Natural History]
Khirani S (2026). [PMID: 42101665](https://pubmed.ncbi.nlm.nih.gov/42101665/). *Eur J Pediatr*. [Epidemiology / Natural History]
van de Velde S (2026). [PMID: 41077824](https://pubmed.ncbi.nlm.nih.gov/41077824/). *Clin Genet*. [Review / Meta-Analysis]
Lopriore P (2026). [PMID: 41538773](https://pubmed.ncbi.nlm.nih.gov/41538773/). *Neurology*. [Epidemiology / Natural History]
Hegde N (2026). [PMID: 35015467](https://pubmed.ncbi.nlm.nih.gov/35015467/). *Unknown Journal*. [Epidemiology / Natural History]
Coppola MR (2026). [PMID: 41159851](https://pubmed.ncbi.nlm.nih.gov/41159851/). *FEBS J*. [Basic Science / Preclinical]
Mekinian A (2026). [PMID: 40787890](https://pubmed.ncbi.nlm.nih.gov/40787890/). *Arthritis Rheumatol*. [Review / Meta-Analysis]
Meurice T (2025). [PMID: 39870193](https://pubmed.ncbi.nlm.nih.gov/39870193/). *J Stomatol Oral Maxillofac Surg*. [Review / Meta-Analysis]
Jacobs J (2025). [PMID: 40836090](https://pubmed.ncbi.nlm.nih.gov/40836090/). *Nature*. [Basic Science / Preclinical]
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 4:31 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Catel-Manzke syndrome